Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Celestica (CLS) Research & Development (2024 - 2025)

Celestica (CLS) has disclosed Research & Development for 2 consecutive years, with $30.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Research & Development rose 29.06% to $30.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $118.2 million, a 51.54% increase, with the full-year FY2025 number at $118.2 million, up 51.54% from a year prior.
  • Research & Development was $30.2 million for Q4 2025 at Celestica, down from $36.4 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $36.4 million in Q3 2025 to a low of $16.5 million in Q1 2024.